Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical pharmacology study of lusutrombopag in thrombocytopenic patients with Child-Pugh class C liver disease
jRCT2080223234Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of lusutrombopag in Thrombocytopenia, chronic liver disease (CLD) and Cirrhosis, sponsored by Shionogi & Co., Ltd.
02
Drugs
lusutrombopag
03
Conditions
Thrombocytopeniachronic liver disease (CLD)Cirrhosis
Beyond the preview
Go deeper on jRCT2080223234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223234.